+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Acute pulmonary vasodilator testing is a critical step in the management of patients with pulmonary arterial hypertension



Acute pulmonary vasodilator testing is a critical step in the management of patients with pulmonary arterial hypertension



Zhonghua Jie He He Hu Xi Za Zhi 31(5): 378-380




(PDF emailed within 1 workday: $29.90)

Accession: 051363170

Download citation: RISBibTeXText

PMID: 18953965


Related references

Management of pulmonary vasodilator therapy in patients with pulmonary arterial hypertension during critical illness. Critical Care 18(5): 523-523, 2015

Red blood cell distribution width predicts responsiveness of acute pulmonary vasodilator testing in patients with idiopathic pulmonary arterial hypertension. Clinica Chimica Acta; International Journal of Clinical Chemistry 446(): 272-276, 2016

Right-heart function related to the results of acute pulmonary vasodilator testing in patients with pulmonary arterial hypertension caused by connective tissue disease. Journal of the American Society of Echocardiography 25(3): 274-279, 2012

Acute pulmonary vasodilator testing with inhaled treprostinil in children with pulmonary arterial hypertension. Pediatric Cardiology 34(4): 1006-1012, 2013

Acute vasodilator testing in idiopathic pulmonary arterial hypertension: must we take NO for the answer?. European Respiratory Journal 33(6): 1247-1249, 2009

Sildenafil versus nitric oxide for acute vasodilator testing in pulmonary arterial hypertension. Pulmonary Circulation 5(2): 305-312, 2015

Pulmonary vasodilator testing and use of calcium channel blockers in pulmonary arterial hypertension. Respiratory Medicine 104(4): 481-496, 2010

Adenosine for pulmonary vasodilator testing in children with idiopathic pulmonary arterial hypertension. Zhonghua Er Ke Za Zhi 49(12): 886-889, 2013

Iloprost for pulmonary vasodilator testing in idiopathic pulmonary arterial hypertension. European Respiratory Journal 33(6): 1354-1360, 2009

Management of pulmonary vasodilator therapy in three pregnancies with pulmonary arterial hypertension. Journal of Obstetrics and Gynaecology Research 43(5): 935-938, 2017

Survival of patients with pulmonary arterial hypertension after the advent of specific pulmonary vasodilator therapies. Revista Medica de Chile 144(7): 829-836, 2016

Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension. Journal of the American College of Cardiology 39(5 Supplement A): 224A, March 6, 2002

Oral sildenafil is an effective specific pulmonary vasodilator in patients with pulmonary arterial hypertension. Acc Current Journal Review 11(6): 20-0, 2002

Inhaled iloprost during acute pulmonary vasodilator testing for preoperative assessment of surgical operability of congenital heart disease with severe pulmonary hypertension. Zhonghua Wai Ke Za Zhi 48(10): 727-730, 2011

Correlation between the embolism area and pulmonary arterial systolic pressure as an indicator of pulmonary arterial hypertension in patients with acute pulmonary thromboembolism. European Review for Medical and Pharmacological Sciences 18(17): 2551-2555, 2015